Literature DB >> 9312063

Induction of apoptosis by DPC4, a transcriptional factor regulated by transforming growth factor-beta through stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling pathway.

A Atfi1, M Buisine, A Mazars, C Gespach.   

Abstract

Many of the actions of serine/threonine kinase receptors for the transforming growth factor-beta (TGFbeta) are mediated by DPC4, a human MAD-related protein identified as a tumor suppressor gene in pancreatic carcinoma. Overexpression of DPC4 is sufficient to induce the activation of gene expression and cell cycle arrest, characteristic of the TGFbeta response. The stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) is also one of the downstream targets required for TGFbeta-mediated signaling. Here we report that expression of the dominant-interfering mutant of various components of the SAPK/JNK cascade specifically blocked both TGFbeta and DPC4-induced gene expression. These dominant-interfering mutants also inhibited TGFbeta-stimulated DPC4 transcriptional activity. Moreover, we find that overexpression of DPC4 causes transfected cells to undergo the morphological changes typical of apoptosis. These findings define a mechanism whereby TGFbeta signals mediated by DPC4 and SAPK/JNK cascade are integrated in the nucleus to activate gene expression and identify a new cellular function for DPC4.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9312063     DOI: 10.1074/jbc.272.40.24731

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells.

Authors:  T A Sohn; G H Su; B Ryu; C J Yeo; S E Kern
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

2.  Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator.

Authors:  T Shioda; R J Lechleider; S L Dunwoodie; H Li; T Yahata; M P de Caestecker; M H Fenner; A B Roberts; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

3.  Mechanism for mutational inactivation of the tumor suppressor Smad2.

Authors:  C Prunier; N Ferrand; B Frottier; M Pessah; A Atfi
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

4.  Macrophages induce apoptosis in proximal tubule cells.

Authors:  Bärbel Lange-Sperandio; Simone Fulda; Alain Vandewalle; Robert L Chevalier
Journal:  Pediatr Nephrol       Date:  2003-03-21       Impact factor: 3.714

5.  Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.

Authors:  H Fahmi; C Cochet; Z Hmama; P Opolon; I Joab
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.

Authors:  Sofia Edlund; Shizhong Bu; Norbert Schuster; Pontus Aspenström; Rainer Heuchel; Nils-Erik Heldin; Peter ten Dijke; Carl-Henrik Heldin; Maréne Landström
Journal:  Mol Biol Cell       Date:  2003-02       Impact factor: 4.138

7.  Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis.

Authors:  I Schwarte-Waldhoff; O V Volpert; N P Bouck; B Sipos; S A Hahn; S Klein-Scory; J Lüttges; G Klöppel; U Graeven; C Eilert-Micus; A Hintelmann; W Schmiegel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

8.  Increased cAMP levels modulate transforming growth factor-beta/Smad-induced expression of extracellular matrix components and other key fibroblast effector functions.

Authors:  Meinhard Schiller; Sylviane Dennler; Ulf Anderegg; Agatha Kokot; Jan C Simon; Thomas A Luger; Alain Mauviel; Markus Böhm
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

9.  Evidence for a role of NF-kappaB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor beta fusion protein.

Authors:  F Besançon; A Atfi; C Gespach; Y E Cayre; M F Bourgeade
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

10.  The role of TGF-beta-1 protein and TGF-beta-R-1 receptor in immune escape mechanism in bladder cancer.

Authors:  Amira Helmy; Olfat Ali Hammam; Tarek Ramzy El Lithy; Mohamed Mohi El Deen Wishahi
Journal:  MedGenMed       Date:  2007-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.